Cadence Capital Management LLC cut its position in Clorox Co (NYSE:CLX) by 5.2% in the 4th quarter, Holdings Channel reports. The firm owned 19,444 shares of the company’s stock after selling 1,065 shares during the period. Cadence Capital Management LLC’s holdings in Clorox were worth $2,892,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of CLX. APG Asset Management N.V. raised its position in Clorox by 38.6% in the fourth quarter. APG Asset Management N.V. now owns 1,804,215 shares of the company’s stock valued at $223,483,000 after purchasing an additional 502,300 shares during the last quarter. Acadian Asset Management LLC raised its position in Clorox by 33.9% in the fourth quarter. Acadian Asset Management LLC now owns 1,049,445 shares of the company’s stock valued at $156,092,000 after purchasing an additional 265,892 shares during the last quarter. JPMorgan Chase & Co. raised its position in Clorox by 63.2% in the third quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock valued at $54,269,000 after purchasing an additional 161,555 shares during the last quarter. Retirement Systems of Alabama raised its position in Clorox by 172.9% in the third quarter. Retirement Systems of Alabama now owns 170,419 shares of the company’s stock valued at $22,480,000 after purchasing an additional 107,972 shares during the last quarter. Finally, Schroder Investment Management Group raised its position in Clorox by 192.9% in the third quarter. Schroder Investment Management Group now owns 155,304 shares of the company’s stock valued at $20,194,000 after purchasing an additional 102,279 shares during the last quarter. Hedge funds and other institutional investors own 73.68% of the company’s stock.
In related news, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.00% of the company’s stock.
Shares of Clorox Co (NYSE:CLX) opened at $127.82 on Thursday. Clorox Co has a one year low of $124.09 and a one year high of $150.40. The company has a market capitalization of $16,790.00, a P/E ratio of 21.06, a P/E/G ratio of 3.11 and a beta of 0.31. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22.
Clorox (NYSE:CLX) last released its earnings results on Friday, February 2nd. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter last year, the firm posted $1.14 earnings per share. The firm’s revenue was up .7% on a year-over-year basis. analysts forecast that Clorox Co will post 6.08 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a yield of 2.63%. Clorox’s dividend payout ratio is currently 55.35%.
COPYRIGHT VIOLATION WARNING: This article was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://sportsperspectives.com/2018/02/08/cadence-capital-management-llc-reduces-holdings-in-clorox-co-clx.html.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.